Investigation of factors relating to neuropsychological change following cardiac surgery

Perfusion

Volumn 22, Issue 1, 2007, Pages 27-33

  Raymond, Paul D ^a,b   Radel, Michael ^b   Ray, Michael J ^b   Hinton Bayre, Anton D ^c   Marsh, Neville ^a  

^a QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^b THE PRINCE CHARLES HOSPITAL   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Cardiopulmonary bypass; Cerebral complications; Coagulation; Heparin; Neurocognitive deficits

Indexed keywords

APROTININ; HEPARIN; PROTEIN S100B; THROMBIN;

ADULT; AGE DISTRIBUTION; AGED; ANTICOAGULATION; ARTICLE; BRAIN EMBOLISM; COGNITION; COGNITIVE DEFECT; COMPUTER ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORRELATION ANALYSIS; FEMALE; FUNCTIONAL ASSESSMENT; GERIATRIC PATIENT; HEMOSTASIS; HUMAN; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGY; OPERATION DURATION; PATIENT ASSESSMENT; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SAMPLE SIZE; SCORING SYSTEM;

AGE FACTORS; AGED; COGNITION DISORDERS; CORONARY ARTERY BYPASS; FEMALE; HEPARIN; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PEPTIDE FRAGMENTS; POSTOPERATIVE PERIOD; PROTHROMBIN; RISK FACTORS; SURGICAL PROCEDURES, ELECTIVE;

EID: 34347384409     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1177/0267659107077952     Document Type: Article

References (31)

1. Kneebone AC, Andrew MJ, Baker RA, Knight JL. Neuropsychologic changes after coronary artery bypass grafting: use of reliable change indices. Ann Thorac Surg 1998; 65: 1320-5.
2. Mahanna EP, Blumenthal JA, White WD, et al. Defining neuropsychological dysfunction after coronary artery bypass grafting. Ann Thorac Surg 1996; 61: 1342-7.
3. Raymond PD, Marsh NA. Alterations to haemostasis following cardiopulmonary bypass and the relationship of these changes to neurocognitive morbidity. Blood Coagul Fibrinolysis 2001; 12: 601-18.
4. Taylor KM. Brain damage during cardiopulmonary bypass. Ann Thorac Surg 1998; 65: S 20-S 26.
5. Kurusz M, Butler BD. Embolic events and cardiopulmonary bypass. In: Gravlee GP, Davis RF, Utley JR (editors). Cardiopulmonary bypass: principles and practice. 1st edition. Baltimore, Maryland, USA: Williams & Wilkins, 1993; 267-90.
6. Pearson DT, Holden MP, Poslad SJ, Murray A, Waterhouse PS. A clinical evaluation of the performance characteristics of one membrane and five bubble oxygenators: gas transfer and gaseous microemboli production. Perfusion 1986; 1: 15-26.
7. Padayachee TS, Parsons S, Theobold R, Linley J, Gosling RG, Deverall PB. The detection of microemboli in the middle cerebral artery during cardiopulmonary bypass: a transcranial Doppler ultrasound investigation using membrane and bubble oxygenators. Ann Thorac Surg 1987; 44: 298-302.
8. Brooker RF, Brown WR, Moody DM, et al. Cardiotomy suction - a major source of brain lipid emboli during cardiopulmonary bypass. Ann Thorac Surg 1998; 65: 1651-5.
9. Harringer W. Capture of particulate emboli during cardiac procedures in which aortic cross-clamp is used. Ann Thorac Surg 2000; 70: 1119-23.
10. Mills NL, Everson CT. Atherosclerosis of the ascending aorta and coronary artery bypass. Pathology, clinical correlates, and operative management. J Thorac Cardiovasc Surg 1991; 102: 546-53.
11. Ura M, Sakata R, Nakayama Y, Goto T. Ultrasonographic demonstration of manipulation-related aortic injuries after cardiac surgery. J Am Coll Cardiol 2000; 35: 1303-10.
12. Powell DH, Kaplan EF, Whitla D, Weintraub S, Catlin R, Funkestein HH. MicroCog assessment of cognitive functioning. San Antonio, TX: The Psychological Corporation, 1993.
13. Raymond PD, Hinton-Bayre AH, Radel M, Ray MJ, Marsh NA. Test-retest norms and reliable change indices for the MicroCog battery in a healthy community population over 50 years of age. Clin Neuropsych 2006; 20: 261-70.
14. McSweeny AJ, Naugle RI, Chelune GJ, Luders H. "T scores for change": an illustration of a regression approach to depicting change in clinical neuropsychology. Clin Neuropsych 1993; 7: 300-12.
15. Temkin NR, Heaton RK, Grant I, Dikmen SS. Detecting significant change in neuropsychological test performance: a comparison of four models. J Int Neuropsychol Soc 1999; 5: 357-69.
16. Raymond PD, Hinton-Bayre AD, Radel M, Ray MJ, Marsh NA. Assessment of statistical change criteria to define significant change in neuropsychological test performance following cardiac surgery. Eur J Cardiothorac Surg 2006; 29: 82-8.
17. Taggart DP, Mazel JW, Bhattacharya K, et al. Comparison of serum S-100β levels during CABG and intracardiac operations. Ann Thorac Surg 1997; 63: 492-6.
18. Kumar P, Dhital K, Hosseinnia M, Patel S, Holt D, Treasure T. S-100 protein release in a range of cardiothoracic surgical procedures. J Thorac Cardiovasc Surg 1997; 113: 953-4.
19. Lindberg L, Olsson AK, Anderson K, Jogi P. Serum S-100 protein levels after pediatric cardiac operations: a possible new marker for postperfusion cerebral injury. J Thorac Cardiovasc Surg 1998; 116: 281-5.
20. Blomquist S, Johnsson P, Luhrs C, et al. The appearance of S-100 protein in serum during and immediately after cardiopulmonary bypass surgery: a possible marker for cerebral injury. J Cardiothorac Vasc Anesth 1997; 11: 699-703.
21. Johnsson P, Lundqvist C, Lindgren A, Ferencz I, Alling C, Stahl E. Cerebral complications after cardiac surgery assessed by S-100 and NSE levels in blood. J Cardiothorac Vasc Anesth 1995; 9: 694-9.
22. Jönsson H, Johnsson P, Alling C, Westaby S, Blomquist S. Significance of serum S100 release after coronary artery bypass grafting. Ann Thorac Surg 1998; 65: 1639-44.
23. Farsak B, Gunaydin S, Yorgancioglu C, Zorlutuna Y. Elevated levels of s-100β correlate with neurocognitive outcome after cardiac surgery. J Cardiovasc Surg 2003; 44: 31-5.
24. Jönsson H, Johnsson P, Alling C, Bäckström M, Bergh C, Blomquist S. S100β after coronary artery surgery: release pattern, source of contamination, and relation to neuropsychological outcome. Ann Thorac Surg 1999; 68: 2202-8.
25. Anderson RE, Hansson LC, Liska J, Settergren G, Vaage J. The effect of cardiotomy suction on the brain injury marker S100β after cardiopulmonary bypass. Ann Thorac Surg 2000; 69: 847-50.
26. Chung JH, Gikakis N, Rao AK, Drake TA, Colman RW, Edmunds LH. Pericardial blood activates the extrinsic coagulation pathway during clinical cardiopulmonary bypass. Circulation 1996; 93: 2014-8.
27. Philippou H, Davidson SJ, Mole MT, Pepper JR, Burman JF, Lane DA. Two-chain factor VIIa generated in the pericardium during surgery with cardiopulmonary bypass - relationship to increased thrombin generation and heparin concentration. Arterioscler Thromb Vasc Biol 1999; 19: 248-54.
28. Philippou H, Adami A, Davidson SJ, Pepper JR, Burman JF, Lane DA. Tissue factor is rapidly elevated in plasma collected from the pericardial cavity during cardiopulmonary bypass. Thromb Haemost 2000; 84: 124-8.
29. Silverstein A. Neurological complications of anticoagulation therapy: a neurologist's review. Arch Intern Med 1979; 139: 217-20.
30. Kasirajan V, Smedira NG, McCarthy JF, Casselman F, Boparai N, McCarthy PM. Risk factors for intracranial hemorrhage in adults on extracorporeal membrane oxygenation. Eur J Cardiothorac Surg 1999; 15: 508-14.
31. Bull BS, Korpman RA, Huse WM, Briggs BD. Heparin therapy during extracorporeal circulation. I. Problems inherent in existing heparin protocols. J Thorac Cardiovasc Surg 1975; 69: 674-84.